“Novel products contain tobacco and/or nicotine, and are therefore addictive and harmful to health. We don’t recommend them as a means for helping smokers quit’’, says Prof. Dr Frank Ulrich Montgomery, CPME President. Full press release available here.

On 16 November 2019, the CPME Board adopted the ’CPME Policy on Novel Tobacco and Nicotine Products’ (CPME 2019/074 FINAL).

On 16 November 2019, the CPME Board adopted the ’CPME Policy on Air Quality and Health’ (CPME 2019/073 FINAL).

On 16 November 2019, the CPME Board adopted the ’CPME Statement on the Medical Treatment of Refugees’ (CPME 2019/071 FINAL).

On 10 October 2019, the CPME Executive Committee adopted the ’CPME consultation response on evaluation of Services of General Economic Interest (SGEI) rules applicable to health and social services and the SGEI de minimis Regulation’ (CPME 2019/092 FINAL).

CPME has co-signed a letter to Politico news organisation raising a concern of tobacco industry sponsoring its newsletters, particularly Politico PRO Health Care. Please find the letter here.

On 20 June 2019, the CPME Executive Committee adopted the ’CPME consultation response on review of Statistical classification of economic activities in the European Community (NACE)’ (CPME 2019/060 FINAL).

On 23 May 2019, the CPME Executive Committee adopted the ’CPME Response to the Public Consultation on the Evaluation of the CAP Measures Applicable to the Wine Sector’ (CPME 2019/059 FINAL).

On 23 May 2019, the CPME Executive Committee adopted the ’CPME reply to Council of Europe’s Committee of Bioethics consultation on the preparation of an additional protocol to the Convention on human rights and biomedicine’ (CPME 2019/057 FINAL)

On 6 April 2019, the CPME Board adopted the “CPME response to public consultation on key principles for electronic product information for human medicines in the EU” (CPME 2019/045)